The EBMT has contributed to the Innovative Medicines Intiative (IMI) consultation on advanced therapies responding to the IMI's proposals in this fast-moving field that includes cellular therapy. All submissions including the EBMT's were published on the IMI web site
on 15 September and will be further discussed at the IMI Stakeholder Forum on 29 September (see link
for more information on the Forum).
IMI is the world's biggest public-private partnership (PPP) in the life sciences. Through the IMI 2 programme, it has a €3.3 billion budget for the period 2014-2024. More information can be found here